Relationship between liver fibrosis and in-hospital outcomes in patients with acute coronary syndrome undergoing PCI. (3rd October 2022)
- Record Type:
- Journal Article
- Title:
- Relationship between liver fibrosis and in-hospital outcomes in patients with acute coronary syndrome undergoing PCI. (3rd October 2022)
- Main Title:
- Relationship between liver fibrosis and in-hospital outcomes in patients with acute coronary syndrome undergoing PCI
- Authors:
- Biccire, F G
Barilla, F
Sammartini, E
Dacierno, E M
Tanzilli, G
Pastori, D - Abstract:
- Abstract: Background: Patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) still experience a high rate of in-hospital complications. Liver fibrosis (LF) is a risk factor for mortality in the general population. However its prognostic role in ACS patients has been poorly investigated. Purpose: We investigated whether the presence of LF detected by the validated fibrosis-4 (FIB-4) score may indicate ACS patients at higher risk of poor outcome. Methods: In the prospective ongoing REAl-world observationaL rEgistry of Acute Coronary Syndrome (REALE-ACS), LF was defined by a FIB-4 score >3.25. The primary endpoint was in-hospital adverse events (AEs) including a composite of in-hospital cardiogenic shock, PEA/asystole, acute pulmonary edema and death. Results: A total of 469 consecutive ACS consecutive patients were enrolled. Overall, 21.1% of patients had a FIB-4 score >3.25. Patients with LF were older, less frequently on P2Y12 inhibitors (p=0.021) and admitted with higher serum levels of white blood cells (p<0.001), neutrophils to lymphocytes ratio (p<0.001), C-reactive protein (p=0.013), high-sensitive troponin T (p<0.001), creatin-kinase MB (p<0.001), D-Dimer levels (p<0.001). STEMI presentation and higher Killip class/GRACE score were more common in the LF group (p<0.001). 71 patients experienced 110 AEs. At the multivariate analysis including clinical and laboratory risk factors, FIB-4 >3.25 (OR 3.1, 95% CI 1.4 to 6.9), admissionAbstract: Background: Patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) still experience a high rate of in-hospital complications. Liver fibrosis (LF) is a risk factor for mortality in the general population. However its prognostic role in ACS patients has been poorly investigated. Purpose: We investigated whether the presence of LF detected by the validated fibrosis-4 (FIB-4) score may indicate ACS patients at higher risk of poor outcome. Methods: In the prospective ongoing REAl-world observationaL rEgistry of Acute Coronary Syndrome (REALE-ACS), LF was defined by a FIB-4 score >3.25. The primary endpoint was in-hospital adverse events (AEs) including a composite of in-hospital cardiogenic shock, PEA/asystole, acute pulmonary edema and death. Results: A total of 469 consecutive ACS consecutive patients were enrolled. Overall, 21.1% of patients had a FIB-4 score >3.25. Patients with LF were older, less frequently on P2Y12 inhibitors (p=0.021) and admitted with higher serum levels of white blood cells (p<0.001), neutrophils to lymphocytes ratio (p<0.001), C-reactive protein (p=0.013), high-sensitive troponin T (p<0.001), creatin-kinase MB (p<0.001), D-Dimer levels (p<0.001). STEMI presentation and higher Killip class/GRACE score were more common in the LF group (p<0.001). 71 patients experienced 110 AEs. At the multivariate analysis including clinical and laboratory risk factors, FIB-4 >3.25 (OR 3.1, 95% CI 1.4 to 6.9), admission left ventricular ejection fraction% below median (OR 9.2, 95% CI 3.9 to 21.7) and Killip class ≥II (OR 6.3, 95% CI 2.2 to 18.4) were the strongest independent predictors of in-hospital AEs. Conclusions: LF detected by FIB-4 score >3.25 was associated with more severe ACS presentation and worse in-hospital AEs irrespective of clinical and laboratory variables. Funding Acknowledgement: Type of funding sources: None. … (more)
- Is Part Of:
- European heart journal. Volume 43(2022)Supplement 2
- Journal:
- European heart journal
- Issue:
- Volume 43(2022)Supplement 2
- Issue Display:
- Volume 43, Issue 2 (2022)
- Year:
- 2022
- Volume:
- 43
- Issue:
- 2
- Issue Sort Value:
- 2022-0043-0002-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-10-03
- Subjects:
- Cardiology -- Periodicals
Heart -- Diseases -- Periodicals
616.12005 - Journal URLs:
- http://eurheartj.oxfordjournals.org/ ↗
http://ukcatalogue.oup.com/ ↗ - DOI:
- 10.1093/eurheartj/ehac544.1489 ↗
- Languages:
- English
- ISSNs:
- 0195-668X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.717500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24111.xml